Who funds vaccine research?

We count 539 funded vaccine projects, active between 2014 and 2034, from 8 funders. The most came from Gates Foundation (163 projects), NIH · NIAID (98 projects) and Wellcome (88 projects). The median award is $3M, across the 522 of 539 projects that list an amount.

Funded projects

539

Funders

8

Median award

$3M

Open calls now

1

Top funders of vaccine research

Projects whose title or summary mentions vaccine. Median award: of the projects that list an amount, in US dollars; “—” when fewer than 3 do.

Open vaccine funding calls

1 open call mentions vaccine today.

• Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed)
  National Institutes of HealthNot specifiedDeadline: February 11, 2027 ·

Forecast: announced, not open yet

3 forecast calls on vaccine. Funders publish forecasts before a call opens; you can't apply to these yet, and dates can change.

• ForecastImproving Protection against Influenza and Other Respiratory Pathogens: the US Flu VE Network
  Centers for Disease Control and Prevention - ERA$1,350,000 – $3,550,000Expected to open October 30, 2026
• ForecastCapacity Building for Global, Regional, and National Immunization Programs
  Centers for Disease Control-GHCUp to $120,000,000Expected to open December 14, 2026
• ForecastCapacity Building for National Immunization Programs in the Eastern Mediterranean Region
  Centers for Disease Control-GHCNot specifiedExpected to open December 14, 2026

Funded vaccine projects

A sample, latest start first, at most three per program.

• Decoding early life exposure and immunity to Streptococcus pyogenes
  Wellcome · £5,000,000 · ends 2034
• CIVICS DATA MANAGEMENT AND COORDINATING CENTER (DMCC)
  NIH · Office of the Director · $3,426,973 · ends 2033
• The Role Of Antibody Feedback In Anti-Viral Humoral Immunity
  Wellcome · £2,252,993 · ends 2033
• PATH — Polio
  Gates Foundation · $14,659,818 · ends 2033
• Phase 3 trial to assess M72/AS01E-4 Mycobacterium tuberculosis (TB) vaccine
  Wellcome · £125,955,160 · ends 2033
• Immune mechanisms shaping airborne influenza transmission
  NIH · NIAID · $3,987,706 · ends 2031
• Center for Rational HCV Vaccine Design & Evaluation
  NIH · NIAID · $3,282,170 · ends 2031
• Protective immunity to HCV and rational vaccine design
  NIH · NIAID · $3,263,400 · ends 2031
• Dartmouth Clinical and Translational Science Institute
  NIH · NCATS · $4,073,191 · ends 2031
• Total Body Nuclear Imaging for the Development of Nanotheranostics
  UKRI · EPSRC · £9,980,399 · ends 2031

How we count

Funded projects come from public award records (NIH RePORTER, NSF, EU CORDIS, UKRI Gateway to Research, Wellcome, the Gates Foundation, DOE, NASA and USDA NIFA) whose title or summary matches “vaccine”. NIH lists each budget year separately; one project counts once. Amounts are as the funder lists them; medians use only projects that list one, in US dollars. Open calls and forecasts are from our listings of October 28, 2026. A project can mention a topic without being mainly about it, so treat the counts as a guide to who funds the area.